Shinoda Jun, Yano Hirohito, Yoshimura Shin-Ichi, Okumura Ayumi, Kaku Yasuhiko, Iwama Toru, Sakai Noboru
Department of Neurosurgery, Gifu University School of Medicine, Gifu, Japan.
J Neurosurg. 2003 Sep;99(3):597-603. doi: 10.3171/jns.2003.99.3.0597.
The authors have recently performed a fluorescence-guided tumor resection procedure by using high-dose fluorescein sodium without any special surgical microscopes for the intraoperative visualization of glioblastoma multiforme (GBM), and they report on the actual procedure and clinicopathological findings. Thirty-two patients with GBMs underwent tumor resection during which this fluorescence-guided procedure was used. Fluorescein sodium (20 mg/kg) was intravenously injected after dural opening at the craniotomy site. The tumor was stained almost homogeneously yellow and the color was intense enough to be readily perceived for resection. The center of the solid lesion was stained a deep yellow and surrounded by a transition zone that was faintly stained. The colored lesion was clearly distinguishable from the unstained zone outside the GBM, particularly in the white matter. Both the deeply and faintly stained regions included endothelial proliferation and dense tumor cells. In the unstained region, less dense tumor cells were consistently revealed; however, no endothelial proliferation could be seen. Gross-total resection (GTR) was successful in 84.4% of the patients who received an injection of fluorescein sodium, which accounted for 100% of those in whom all the visible yellow color (both the deeply and faintly stained regions) was judged to have been resected during operation. Gross-total resection was performed in 100% of the patients who underwent the fluorescence-guided procedure and assigned to Stage I, a GBM stage in which, as a therapeutic policy, the tumor should be resected as radically as possible. The GTR rates in patients who received fluorescein sodium were significantly higher than those in patients who did not (73 patients with GBMs who underwent tumor resection without the fluorescence-guided procedure). Although the extent of surgery was revealed to be one of the significant and independent prognostic factors for GBM, the fluorescein sodium-guided resection procedure was not a significant or independent prognostic factor in this series. This surgical procedure does not require any special surgical microscopic equipment and is simple, safe, useful, readily accomplished, and universally available for resection of GBMs. Its efficacy simplifies the surgical procedure of navigating the stained lesion from the unstained area to achieve GTR of GBMs, which can be demonstrated on magnetic resonance images.
作者最近采用高剂量荧光素钠进行了荧光引导下的肿瘤切除手术,术中未使用任何特殊手术显微镜来可视化多形性胶质母细胞瘤(GBM),并报告了实际手术过程及临床病理结果。32例GBM患者在肿瘤切除术中采用了这种荧光引导手术。开颅硬膜打开后,静脉注射荧光素钠(20mg/kg)。肿瘤几乎被均匀地染成黄色,颜色强度足以在切除时轻易识别。实性病变中心染成深黄色,周围是淡染的过渡区。染色的病变与GBM外未染色区域明显区分,尤其是在白质中。深染和淡染区域均有内皮细胞增生和密集的肿瘤细胞。在未染色区域,始终可见密度较低的肿瘤细胞;然而,未见内皮细胞增生。接受荧光素钠注射的患者中,84.4%成功实现了大体全切(GTR),这占所有术中判定已切除所有可见黄色区域(深染和淡染区域)患者的100%。接受荧光引导手术且被归为I期(作为治疗策略,该期GBM应尽可能彻底切除)的患者中,100%实现了大体全切。接受荧光素钠治疗的患者的GTR率显著高于未接受荧光素钠治疗的患者(73例GBM患者在未进行荧光引导手术的情况下接受了肿瘤切除)。尽管手术范围被证明是GBM的重要独立预后因素之一,但在本系列研究中,荧光素钠引导的切除手术并非重要或独立的预后因素。该手术不需要任何特殊的手术显微镜设备,操作简单、安全、有用、易于完成,并且普遍适用于GBM的切除。其有效性简化了从未染色区域导航至染色病变以实现GBM大体全切的手术过程,这在磁共振图像上可以得到证实。